Published in Transpl Int on June 12, 2007
Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era. Dig Dis Sci (2011) 0.88
Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence. Ann Gastroenterol (2015) 0.79
Current status of multimodal & combination therapy for hepatocellular carcinoma. Indian J Med Res (2012) 0.78
Chemoembolization decreases drop-off risk of hepatocellular carcinoma patients on the liver transplant list. Cardiovasc Intervent Radiol (2010) 0.76
A Decade of Experience Using mTor Inhibitors in Liver Transplantation. J Transplant (2011) 0.76
Liver Transplantation for Hepatocellular Carcinoma: A Single Center Resume Overlooking Four Decades of Experience. J Transplant (2016) 0.75
Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med (2002) 6.64
Choledochoduodenostomy is a safe alternative to Roux-en-Y choledochojejunostomy for biliary reconstruction in liver transplantation. World J Surg (2009) 3.47
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
Clinical risk factors for portopulmonary hypertension. Hepatology (2008) 2.62
Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol (2010) 2.41
Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2008) 2.30
Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. Hypertension (2006) 2.11
Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension (2005) 1.95
Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med (2006) 1.94
Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90
Language function and dysfunction in corticobasal degeneration. Neurology (2003) 1.78
Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD. Liver Transpl (2004) 1.66
Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications. Liver Transpl (2003) 1.61
Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. Gastroenterology (2010) 1.60
Retracted Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver. Proc Natl Acad Sci U S A (2013) 1.59
Health-related quality of life and survival in liver transplant candidates. Liver Transpl (2010) 1.55
Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C. Liver Transpl (2012) 1.54
Elimination of indocyanine green in the perioperative evaluation of donor liver function. Anesth Analg (2002) 1.53
Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology (2008) 1.50
Sirolimus--it doesn't deserve its bad Rap(a). J Hepatol (2011) 1.49
Comprehensive cost comparison of adult-adult right hepatic lobe living-donor liver transplantation with cadaveric transplantation. Transplantation (2003) 1.46
Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med (2009) 1.44
Herpes simplex in a liver transplant recipient. Liver Transpl (2006) 1.39
Promotion of altruistic donation. Transplantation (2009) 1.33
Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl (2003) 1.31
Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain (2010) 1.30
Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice. Mol Genet Metab (2009) 1.26
Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course. Liver Transpl (2008) 1.19
Frequency and prognostic value of cognitive disorders in stroke patients. Dement Geriatr Cogn Disord (2008) 1.19
Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Liver Transpl (2008) 1.18
Immunosuppression: evolution in practice and trends, 1993-2003. Am J Transplant (2005) 1.17
Metastatic breast cancer presenting as acute liver failure. Gastroenterol Hepatol (N Y) (2011) 1.15
Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg (2010) 1.13
A multicenter evaluation of safety of early extubation in liver transplant recipients. Liver Transpl (2007) 1.10
Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience. Liver Transpl (2011) 1.09
Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men. Hepatology (2011) 1.09
Adult-adult right hepatic lobe living donor liver transplantation for status 2a patients: too little, too late. Liver Transpl (2002) 1.08
Development of the allocation system for deceased donor liver transplantation. Clin Med Res (2005) 1.06
Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transpl (2011) 1.06
A survey of current liver biopsy practice patterns. J Clin Gastroenterol (2002) 1.03
The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl (2006) 1.03
Microscopic and histological examination of the mouse hindpaw digit and flexor tendon arrangement with 3D reconstruction. J Anat (2006) 1.03
Organ trafficking and transplant tourism: the role of global professional ethical standards-the 2008 Declaration of Istanbul. Transplantation (2013) 1.03
Donor complications following laparoscopic compared to hand-assisted living donor nephrectomy: an analysis of the literature. J Transplant (2010) 1.02
A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. Am J Transplant (2005) 1.02
Endoscopic gallbladder stent placement for treatment of symptomatic cholelithiasis in patients with end-stage liver disease. Am J Gastroenterol (2006) 1.01
Atrial septal perforation from TIPS stent migration. J Vasc Interv Radiol (2004) 1.00
Incentives for organ donation: proposed standards for an internationally acceptable system. Am J Transplant (2011) 0.99
Proteomic analysis of human mesenteric lymph. Shock (2011) 0.98
Consumptive hypothyroidism resulting from hepatic vascular tumors in an athyreotic adult. J Clin Endocrinol Metab (2011) 0.95
Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy. Am J Hypertens (2009) 0.95
Dominance of Mycoplasma in the guts of the Long-Jawed Mudsucker, Gillichthys mirabilis, from five California salt marshes. Environ Microbiol (2007) 0.92
Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab (2012) 0.91
Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant (2004) 0.90
Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation. J Hepatol (2013) 0.90
Focusing on children's inhalation dosimetry and health effects for risk assessment: an introduction. J Toxicol Environ Health A (2008) 0.90
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. Transplantation (2003) 0.89
Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion. Hepatology (2013) 0.88
May-Thurner syndrome complicating left-sided renal transplant. Transplantation (2010) 0.88
Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study. Liver Transpl (2012) 0.88
Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study. Transplantation (2015) 0.88
Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl (2003) 0.88
Deposition, imaging, and clearance: what remains to be done? J Aerosol Med Pulm Drug Deliv (2010) 0.88